Venetoclax and beyond: New Horizons in CLL and AML therapy

Expert Rev Anticancer Ther. 2025 Jan 4:1-4. doi: 10.1080/14737140.2025.2449944. Online ahead of print.

Authors

Matteo Molica¹, Salvatore Perrone²

Affiliations

¹ Department of Hematology-Oncology, Azienda Universitaria Ospedaliera Renato Dulbecco, Catanzaro, Italy.
² Department of Hematology, S. M. Goretti Hospital, Polo Universitario Pontino, Latina, Italy.

PMID: 39750299
DOI: 10.1080/14737140.2025.2449944

No abstract available

Keywords: Venetoclax; acute myeloid leukemia; chronic lymphocytic leukemia; ibrutinib; venetoclax analogs.

Publication types

Editorial